Next 10 |
home / stock / orinf / orinf news
2024-04-27 12:32:06 ET ORION Holdings Corp. (ORINF) Q1 2024 Earnings Conference Call April 25, 2024, 06:30 AM ET Company Participants Tuukka Hirvonen - Investor Relations & Financial Communications Officer Liisa Hurme - President, CEO & Chairman of Executive ...
2024-04-25 11:55:46 ET More on ORION Holdings Corp. Dividend scorecard for ORION Holdings Corp. Financial information for ORION Holdings Corp. Read the full article on Seeking Alpha For further details see: ORION Holdings reports Q1 results
2024-03-20 04:08:04 ET More on Orion Oyj Orion Oyj (ORINF) Q4 2023 Earnings Call Transcript Orion collaborates with Glykos to develop next-generation ADCs Historical earnings data for Orion Oyj Dividend scorecard for Orion Oyj Financial information fo...
2024-02-13 13:42:10 ET Orion Oyj (ORINF) Q4 2023 Earnings Call Transcript February 13, 2024 6:30 AM ET Company Participants Tuukka Hirvonen - Investor Relations & Financial Communications Officer Liisa Hurme - President, CEO & Chairman of Executive Management...
2024-02-13 09:58:41 ET More on Orion Oyj Orion collaborates with Glykos to develop next-generation ADCs Historical earnings data for Orion Oyj Dividend scorecard for Orion Oyj Financial information for Orion Oyj Read the full article on Seeking Alph...
ORION CORPORATION PRESS RELEASE 26 JANUARY 2024 at 09.00 EET Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024 Orion presented yesterday at the 2024 ASCO GU Cancers Symposium a poster with additional data from the ongoing Phase II CYPIDES trial evaluating the safety...
2024-01-08 04:59:59 ET More on Orion: Historical earnings data for Orion Oyj Dividend scorecard for Orion Oyj Financial information for Orion Oyj For further details see: Orion collaborates with Glykos to develop next-generation ADCs
ORION CORPORATION PRESS RELEASE 8 JANUARY 2024 at 09.00 EET Orion and Glykos announce research collaboration and licensing agreement to develop next-generation ADCs Orion Corporation and Glykos Finland Oy announced today that they have entered into a research collaborat...
ORION CORPORATION PRESS RELEASE 05 JANUARY 2023 at 13:45 EET Orion and MSD Announce Initiation of Two Phase 3 Trials Evaluating ODM-208/MK5684 in Certain Patients with Metastatic Castration-Resistant Prostate Cancer OMAHA1 and OMAHA2a are the first Phase 3 trials to be initiated for...
ORION CORPORATION PRESS RELEASE 27 DECEMBER 2023 at 11:00 EET NEJM Evidence publishes results from Phase I/IIa CYPIDES trial with ODM-208 The NEJM Evidence has published interim data from the first part of Phase I/II CYPIDES trial evaluating the safety and efficacy of ODM-208 (or MK-5...
News, Short Squeeze, Breakout and More Instantly...
Orion Corp New B Shs Company Name:
ORINF Stock Symbol:
OTCMKTS Market:
ORION CORPORATION PRESS RELEASE 26 JANUARY 2024 at 09.00 EET Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024 Orion presented yesterday at the 2024 ASCO GU Cancers Symposium a poster with additional data from the ongoing Phase II CYPIDES trial evaluating the safety...
ORION CORPORATION PRESS RELEASE 8 JANUARY 2024 at 09.00 EET Orion and Glykos announce research collaboration and licensing agreement to develop next-generation ADCs Orion Corporation and Glykos Finland Oy announced today that they have entered into a research collaborat...
ORION CORPORATION PRESS RELEASE 05 JANUARY 2023 at 13:45 EET Orion and MSD Announce Initiation of Two Phase 3 Trials Evaluating ODM-208/MK5684 in Certain Patients with Metastatic Castration-Resistant Prostate Cancer OMAHA1 and OMAHA2a are the first Phase 3 trials to be initiated for...